Search Results

The timing of the last dose of GLP-1 agonist like Ozempic can influence anesthesia-related complications

Use of GLP-1 Receptor Agonists for Weight Loss Leads to Shortages for Diabetes Patients

Integrating pharmacology, personalized nutrition, and precision medicine to improve management of obesity and type 2 diabetes.

Findings suggest GLP-1s may have protective properties for bone health.

New Medicare Bridge coverage expands access to GLP-1 weight-loss drugs for eligible beneficiaries, but important limits remain.

Learn how RoenRx’s online GLP-1 weight-loss program works, including costs, medications, and ongoing support.